Mycobacterium tuberculosis Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-di-amp

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Bai, Yinlan ^a   Yang, Jun ^a   Zhou, Xin ^b,c   Ding, Xinxin ^b,c   Eisele, Leslie E ^b   Bai, Guangchun ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BACTERIAL ENZYME; CYCLIC DIADENOSINE MONOPHOSPHATE; CYCLIC DIGUANOSINE MONOPHOSPHATE; DIADENYLATE CYCLASE; OCTAMER; POLYMER; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; POLYMERIZATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TETRAMERIZATION; THIN LAYER CHROMATOGRAPHY; ULTRACENTRIFUGATION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; DINUCLEOSIDE PHOSPHATES; ENZYME ACTIVATION; HYDROGEN-ION CONCENTRATION; IONS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PHOSPHORUS-OXYGEN LYASES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); DISA; MYCOBACTERIUM TUBERCULOSIS;

EID: 84859807730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035206     Document Type: Article

References (42)

1. Aziz MA, Wright A, (2005) The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases. Clin Infect Dis 41 (Suppl 4): S258-262.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
3. Espinal MA, (2003) The global situation of MDR-TB. Tuberculosis (Edinb) 83: 44-51.
4. Fine PE, (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345.
5. Gomelsky M, (2011) cAMP, c-di-GMP, c-di-AMP and now cGMP: bacteria use them all! Mol Microbiol 79: 562-565.
6. Botsford JL, Harman JG, (1992) Cyclic AMP in prokaryotes. Microbiol Rev 56: 100-122.
7. McCue LA, McDonough KA, Lawrence CE, (2000) Functional classification of cNMP-binding proteins and nucleotide cyclases with implications for novel regulatory pathways in Mycobacterium tuberculosis. Genome Res 10: 204-219.
8. Bai G, Knapp GS, McDonough KA, (2011) Cyclic AMP signalling in mycobacteria: redirecting the conversation with a common currency. Cell Microbiol 13: 349-358.
9. Shenoy AR, Visweswariah SS, (2006) New messages from old messengers: cAMP and mycobacteria. Trends Microbiol 14: 543-550.
10. Shenoy AR, Visweswariah SS, (2006) Mycobacterial adenylyl cyclases: biochemical diversity and structural plasticity. FEBS Lett 580: 3344-3352.
11. Agarwal N, Lamichhane G, Gupta R, Nolan S, Bishai WR, (2009) Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature 460: 98-102.
12. Lowrie DB, Jackett PS, Ratcliffe NA, (1975) Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomes. Nature 254: 600-602.
13. Bai G, Schaak DD, McDonough KA, (2009) cAMP levels within Mycobacterium tuberculosis and Mycobacterium bovis BCG increase upon infection of macrophages. FEMS Immunol Med Microbiol 55: 68-73.
14. Hengge R, (2009) Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol 7: 263-273.
15. Tamayo R, Pratt JT, Camilli A, (2007) Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu Rev Microbiol 61: 131-148.
16. Rao F, See RY, Zhang D, Toh DC, Ji Q, et al. (2010) YybT is a signaling protein that contains a cyclic dinucleotide phosphodiesterase domain and a GGDEF domain with ATPase activity. J Biol Chem 285: 473-482.
17. Camilli A, Bassler BL, (2006) Bacterial small-molecule signaling pathways. Science 311: 1113-1116.
18. Cotter PA, Stibitz S, (2007) c-di-GMP-mediated regulation of virulence and biofilm formation. Curr Opin Microbiol 10: 17-23.
19. Jenal U, Malone J, (2006) Mechanisms of cyclic-di-GMP signaling in bacteria. Annu Rev Genet 40: 385-407.
20. Pesavento C, Hengge R, (2009) Bacterial nucleotide-based second messengers. Curr Opin Microbiol 12: 170-176.
21. Romling U, (2008) Great times for small molecules: c-di-AMP, a second messenger candidate in Bacteria and Archaea. Sci Signal 1: pe39.
22. Witte G, Hartung S, Buttner K, Hopfner KP, (2008) Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol Cell 30: 167-178.
23. Woodward JJ, Iavarone AT, Portnoy DA, (2010) c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328: 1703-1705.
24. Corrigan RM, Abbott JC, Burhenne H, Kaever V, Grundling A, (2011) c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress. PLoS Pathog 7: e1002217.
25. Kamegaya T, Kuroda K, Hayakawa Y, (2011) Identification of a Streptococcus pyogenes SF370 gene involved in production of c-di-AMP. Nagoya J Med Sci 73: 49-57.
26. Oppenheimer-Shaanan Y, Wexselblatt E, Katzhendler J, Yavin E, Ben-Yehuda S, (2011) c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep 12: 594-601.
27. Jin L, Hill KK, Filak H, Mogan J, Knowles H, et al. (2011) MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol 187: 2595-2601.
28. Sauer JD, Sotelo-Troha K, von Moltke J, Monroe KM, Rae CS, et al. (2011) The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun 79: 688-694.
29. Ebensen T, Libanova R, Schulze K, Yevsa T, Morr M, et al. (2011) Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant. Vaccine 29: 5210-5220.
30. Florczyk MA, McCue LA, Purkayastha A, Currenti E, Wolin MJ, et al. (2003) A family of acr-coregulated Mycobacterium tuberculosis genes shares a common DNA motif and requires Rv3133c (dosR or devR) for expression. Infect Immun 71: 5332-5343.
31. Bai G, Schaak DD, Smith EA, McDonough KA, (2011) Dysregulation of serine biosynthesis contributes to the growth defect of a Mycobacterium tuberculosis crp mutant. Mol Microbiol 82: 180-198.
32. Bai G, Gazdik MA, Schaak DD, McDonough KA, (2007) The Mycobacterium bovis BCG cyclic AMP receptor-like protein is a functional DNA binding protein in vitro and in vivo, but its activity differs from that of its M. tuberculosis ortholog, Rv3676. Infect Immun 75: 5509-5517.
33. Bai G, McCue LA, McDonough KA, (2005) Characterization of Mycobacterium tuberculosis Rv3676 (CRPMt), a cyclic AMP receptor protein-like DNA binding protein. J Bacteriol 187: 7795-7804.
34. Eisele LE, Chave KJ, Lehning AC, Ryan TJ, (2006) Characterization of Human gamma-glutamyl hydrolase in solution demonstrates that the enzyme is a non-dissociating homodimer. Biochim Biophys Acta 1764: 1479-1486.
35. Schuck P, (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78: 1606-1619.
36. Dam J, Schuck P, (2004) Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol 384: 185-212.
37. Christen M, Christen B, Folcher M, Schauerte A, Jenal U, (2005) Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP. J Biol Chem 280: 30829-30837.
38. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M, (2005) Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J Bacteriol 187: 1792-1798.
39. Linder JU, Schultz A, Schultz JE, (2002) Adenylyl cyclase Rv1264 from Mycobacterium tuberculosis has an autoinhibitory N-terminal domain. J Biol Chem 277: 15271-15276.
40. Shenoy AR, Sreenath N, Podobnik M, Kovacevic M, Visweswariah SS, (2005) The Rv0805 gene from Mycobacterium tuberculosis encodes a 3′,5′-cyclic nucleotide phosphodiesterase: biochemical and mutational analysis. Biochemistry 44: 15695-15704.
41. Keppetipola N, Shuman S, (2008) A phosphate-binding histidine of binuclear metallophosphodiesterase enzymes is a determinant of 2′,3′-cyclic nucleotide phosphodiesterase activity. J Biol Chem 283: 30942-30949.
42. Guo YL, Seebacher T, Kurz U, Linder JU, Schultz JE, (2001) Adenylyl cyclase Rv1625c of Mycobacterium tuberculosis: a progenitor of mammalian adenylyl cyclases. EMBO J 20: 3667-3675.